• Follow the Money: Remote Patient Monitoring, Real-World Data Networks, Trial Diversity

    Clinical Research News | PatientsLikeMe raises a new round of funding to expand, and several companies get investments for remote patient monitoring and medication adherence. Mount Sinai leads team tasked with decreasing the disparities in cancer trials. And new investment funds for late-stage companies and public health.

    Apr 1, 2021

  • How Cerevel Therapeutics Put Hybrid Trials Into Practice

    Clinical Research News | Cerevel Therapeutics is looking at new studies in a different way after test-driving an assortment of virtual trial options when the pandemic hit. Remote site initiation visits and remote monitoring will be permanent fixtures moving forward, and the incorporation of home health visits also appears promising, according to Laura Whitmore, director of clinical operations oversight

    Mar 31, 2021

  • Interest Brewing In A One-Stop Platform For Trial Participants

    Clinical Research News | A panel discussion on the move toward “platform thinking” in pharma roused lively discussion and exchange with attendees at the recent Summit for Clinical Ops Executives (SCOPE). Interest was particularly high in development of a common platform catering to the needs of patients and disconnected from any drug, protocol, or sponsor.

    Mar 30, 2021

  • Takeda Using Chatbot To Improve Patient-Centricity And Trial Design

    Clinical Research News | Takeda Pharmaceuticals has developed a digital chatbot assistant to provide integrated and continuous support for patients with chronic diseases at risk of serious event occurrences and frequent emergency room visits. The learnings are expected to help clinical trials become more patient-centric and less labor-intensive to conduct.

    Mar 29, 2021

  • The Importance of Early Phase Trials in Precision Oncology

    Clinical Research News | Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we believe that the greatest impact of precision oncology has been in the design of early-phase trials.

    Mar 25, 2021

  • Data Exchange Standards Are Focus Of TransCelerate’s eSource Initiative

    Clinical Research News | TransCelerate’s eSource initiative supporting decentralized clinical trials aims to add efficiency to the clinical research process by facilitating the exchange of data between sites and sponsors and “filling the gaps” in the primary data interchange standards governing electronic health record (EHR) systems.

    Mar 24, 2021

  • AbbVie Quantifying Burden Of Clinical Trial Participation

    Clinical Research News | AbbVie is developing a patient burden algorithm to quantify the onus of trial-related procedures on study participants, according to Allam Fakhoury, PharmD, the company’s head of portfolio design and execution, at a presentation he made at last week’s Summit for Clinical Ops Executives (SCOPE).

    Mar 23, 2021

  • AstraZeneca’s Pragmatic Approach To Clinical Research

    Clinical Research News | AstraZeneca has been embracing the use of real-world evidence (RWE) for clinical research to help overcome some of the new and perennial challenges in moving medicines to market. The company has been actively using RWE to optimize study protocols, assess new opportunities, employ external arms/comparators, enable pragmatic clinical trials, and transform endpoints, she reports.

    Mar 22, 2021

  • CVS Health, Salesforce Enlarging Their Roles In Clinical Research

    Clinical Research News | Hyper-local engagement and hyper-customized communications are both are necessary as the industry continues its shift toward decentralized clinical trial strategies, and the needs have prompted the entry of non-pharma companies into the clinical research space, including CVS Health and Salesforce, according to a keynote presentation at the recent Summit for Clinical Ops Executives (SCOPE).

    Mar 19, 2021

  • Reengineering Trials Is An Organizational Imperative

    Clinical Research News | In the space of a year, the clinical trials enterprise has made “a decade of progress” in the way it conducts studies, according to Harlan Krumholz, cofounder of Hugo Health, who spoke about participant-partnered research at the recent Summit for Clinical Ops Executives (SCOPE).

    Mar 18, 2021

  • How Active Safety Analytics Can Help Pharma Companies Increase Public Confidence in COVID-19 Vaccines

    Clinical Research News | The biggest US vaccine initiative is currently underway, with 32.3 million people having received at least one dose of either Pfizer-BioNTech or Moderna’s COVID-19 vaccine—including 37 million who have been fully vaccinated—as of the second week of March.

    Mar 17, 2021

  • Award-Winning Participant Engagement Strategies

    Clinical Research News | A lot of technology companies talk about the importance of patient input on the products they build, but Medidata is the first to hire patient advocates to provide feedback throughout the development life cycle—specifically, the patient cloud products it deploys in clinical trials, says Alicia Staley, senior director of patient engagement. “We’ve put a process in place to hold our own feet to the fire,” she says. “If our patient advocates haven’t looked at something rolling out the door, an explanation is expected as to why not.”

    Mar 16, 2021

  • How To Integrate The Patient Voice Into Trial Design

    Clinical Research News | The need to listen to the voice of patients at the right time, in the right context, and in their own language was a dominant theme of a live panel session at the recent Summit for Clinical Ops Executives (SCOPE) where views were shared on integrating patient insights into clinical trial design.

    Mar 15, 2021

  • Clinical Control Tower Providing Near-Real-Time View Of GSK Trials

    Clinical Research News | Thanks to COVID-19, asset leads at GlaxoSmithKline (GSK) can now tap a Clinical Control Tower for answers to five critical questions about how studies are progressing and if they are veering off course. The platform was developed last year to enable trial leaders to maintain business continuity during the pandemic.

    Mar 12, 2021

  • Antibodies Plus Vaccines, RWD on Post-Shot Reactions: COVID-19 Updates

    Clinical Research News | Top COVID-19 news and research stories of the week: real-world data from Mass General Brigham staff after vaccination, antibodies and the jab, and springtime impacts on infection rates.

    Mar 12, 2021

  • SCOPE 2021 Highlights New Value Props From Vendors

    Clinical Research News | New products, acquisitions, and a Cannes Film Festival award—some of the noteworthy announcements heard on the virtual exhibit hall floor during SCOPE 2021.

    Mar 11, 2021